Skip to Content

Fresenius SE & Co KGaA ADR FSNUY Stock Quote

| Rating as of


Last close prices updated as of May 30, 2023, 3:59 PM EST | USD
  • Last Close 7.19
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Investment Style Mid Value
  • Day Range 6.95  –  7.13
  • Year Range 4.79  –  8.64
  • Market Cap 15.8382 Bil
  • Volume / Avg 36,724.0 /  45,528.1
  • Price / Sales 0.37
  • Price / Book 0.74
  • Forward Div Yield 3.45%
  • Trailing Div Yield 3.53%

Morningstar‘s Stock Analysis FSNUY

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics FSNUY

Company Profile FSNUY

Business Description

Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care, which accounts for about half of its consolidated revenue. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.

Else-Kroener-Strasse 1
Bad Homburg, HE, 61352, DEU
Industry Medical Care Facilities
Employees 316,920

Competitors & Peers FSNUY

Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of FSNUY’s competitive advantage.

Fresenius SE & Co KGaA ADR


Baxter International Inc


DaVita Inc


ICU Medical Inc

−$0.16 (2.23%) −$0.96 (2.33%) −$1.86 (1.97%) −$2.27 (1.31%)
Market Cap
15.84 Bil20.40 Bil8.38 Bil4.11 Bil
Medical Care Facilities Medical Instruments & Supplies Medical Care Facilities Medical Instruments & Supplies

* Trading data in this section is delayed by at least 15 minutes.

FAQs for Fresenius SE & Co KGaA ADR Stock

Yes. FSNUY has a forward dividend yield of 3.45%. See FSNUY’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

FSNUY’s market cap is 15.84 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

FSNUY’s stock style is Mid Value.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

FSNUY’s price/sales is 0.38.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

FSNUY’s price/forward earnings is 11.21.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

FSNUY’s price/book is 0.74.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See FSNUY’s valuation ratios compared to the Market Index.

FSNUY’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare FSNUY’s historical performance against its industry peers and the overall market.